Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Acquisitions & Divestments (2016 - 2020)

Cumberland Pharmaceuticals' Change in Acquisitions & Divestments history spans 9 years, with the latest figure at -$460888.0 for Q4 2020.

  • For Q4 2020, Change in Acquisitions & Divestments fell 110.53% year-over-year to -$460888.0; the TTM value through Sep 2020 reached $4.8 million, down 69.17%, while the annual FY2019 figure was $20.1 million, 24.44% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2020 was -$460888.0 at Cumberland Pharmaceuticals, down from $460888.0 in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $9.2 million in Q3 2018 and bottomed at -$460888.0 in Q4 2020.
  • The 5-year median for Change in Acquisitions & Divestments is $2.1 million (2016), against an average of $3.2 million.
  • The largest annual shift saw Change in Acquisitions & Divestments surged 972.73% in 2017 before it crashed 110.53% in 2020.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $812366.0 in 2016, then skyrocketed by 359.95% to $3.7 million in 2017, then surged by 146.71% to $9.2 million in 2018, then plummeted by 52.53% to $4.4 million in 2019, then plummeted by 110.53% to -$460888.0 in 2020.
  • Per Business Quant, the three most recent readings for CPIX's Change in Acquisitions & Divestments are -$460888.0 (Q4 2020), $460888.0 (Q3 2020), and $4.4 million (Q4 2019).